BAP1 and intrahepatic cholangiocarcinoma: Given the finding that somatic BAP1 mutations have been reported in a significant proportion of intrahepatic cholangiocarcinomas (CCA) [22,23,34], it is possible that cancers arising from BAP1 mutations occur in the pancreas, considering the morphological similarity and anatomical proximity of the entire pancreatobiliary system.